Skip to content
by Legal Desire
SIGN IN GO PRO
18 June 2021

Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics Holdings Limited (02171.HK)’s mainboard listing on the Stock Exchange of Hong Kong.

Capital Markets & IPO Healthcare & Life Sciences Completed ChinaHong KongUnited States

Advising firms

Herbert Smith Freehills Kramer
Sponsor acting for Goldman Sachs and UBS

Deal team

17 lawyers named
LawyerFirmSeniorityPracticeOffice
Matt Emsley Lead Herbert Smith Freehills Kramer Partner Not stated Hong Kong
Stanley Xie Lead Herbert Smith Freehills Kramer Partner Not stated Not stated
Lucy Yao Lead Herbert Smith Freehills Kramer Other Not stated Not stated
Siddhartha Sivaramakrishnan Herbert Smith Freehills Kramer Partner Not stated Singapore
George Wu Herbert Smith Freehills Kramer Of counsel Not stated Hong Kong
Maisie Ko Herbert Smith Freehills Kramer Senior associate Not stated Hong Kong
Echo Shen Herbert Smith Freehills Kramer Associate Not stated Hong Kong
Angela Yuen Herbert Smith Freehills Kramer Associate Not stated Hong Kong
Hilary Chong Herbert Smith Freehills Kramer Other Not stated Hong Kong
Sean Ji Herbert Smith Freehills Kramer Associate Not stated Not stated
Sunny Li Herbert Smith Freehills Kramer Other Not stated Sydney
Jasmin Tsang Herbert Smith Freehills Kramer Trainee Not stated Hong Kong
Alisha Chan Herbert Smith Freehills Kramer Other Not stated Not stated
Jessica Sun Herbert Smith Freehills Kramer Other Not stated Not stated
Helen Liang Herbert Smith Freehills Kramer Other Not stated Not stated
Selina Wang Herbert Smith Freehills Kramer Other Not stated Not stated
Shawna Peng Herbert Smith Freehills Kramer Other Not stated Not stated

14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 400m (approximately US$400 million)
What the figure measures
Issue size
Client
Goldman Sachs and UBSSponsor
Counterparties
CARsgen Therapeutics Holdings Limited (Issuer)